[Platelet function inhibitors as a way of arterial thrombosis prevention in the diabetic].
Lecompte
T
T
Service d'Hématologie biologique (hémostase), CHU et Faculté de Médecine de Nancy, 54035 Nancy.
D001241:Aspirin / Q000627:therapeutic use; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000517:prevention & control; D005602:France; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin